IBM Shares Under Fire From Legal Risk and Rising Rates, Even as Citi and Partnerships Offer Support

IBM shares slide 1.2% after a sealed whistleblower lawsuit alleging cyberattack cover-ups is unsealed, while rising Treasury yields weigh. Citigroup raises price target to $375 on AI and quantum potential.

IBM’s stock is navigating a turbulent stretch, with a newly unsealed whistleblower lawsuit adding a layer of legal uncertainty to the macro pressures already weighing on the shares. The technology giant closed Thursday at €260.65 before sliding 1.21% on Friday to €257.50, after an intraday plunge that reached as much as 6.4%.

The legal development surfaced on June 5, when a lawsuit filed by former IBM vice president of threat analysis William Barlow was made public. The case, initially lodged under seal in 2020, accuses IBM and AT&T of concealing repeated cyberattacks by foreign state-linked hackers on cloud infrastructure used by parts of the U.S. government, including the military. The U.S. government opted not to intervene, but the allegations strike at the very heart of IBM’s value proposition for large public-sector and enterprise clients: trust in system security and integrity.

That reputational risk arrived just as the broader tech sector was hit by a familiar headwind. Rising Treasury yields and a stronger-than-expected ADP jobs report — 122,000 new positions versus the 110,000 forecast — dampened hopes for near-term interest rate relief. For a company like IBM, whose corporate customers finance long-term IT projects, higher financing costs tend to tighten spending scrutiny. The caution was echoed by GitLab’s announcement that it would cut 14% of its workforce and exit 22 countries, a sign that cost discipline remains widespread across the software industry.

Yet against this backdrop, Citigroup has placed a notable counterweight. Analyst Fatima Boolani reiterated a buy rating on June 3 and raised her price target sharply from $285 to $375. Her conviction rests on two long-range bets: artificial intelligence and quantum computing. Boolani argued that IBM is undervalued and misunderstood, pointing to a structural cash-flow advantage over many large-cap tech peers. She also highlighted the estimated $850 billion addressable quantum market and IBM’s recent CHIPS Act funding as signals of strategic positioning.

The macro and legal pressures follow a period of strong momentum. Only last week, IBM jumped 6% after being named a partner for Nvidia’s new Vera-Rubin AI accelerators, tasked with delivering systems, cloud services and secure storage for enterprise AI infrastructure. That partnership feeds into a broader push to monetize corporate AI investments.

IBM is also deepening ties with Google Cloud through a newly formed consulting unit that combines its Consulting Advantage platform with Google’s Gemini Enterprise Agent Platform. The two companies see a multibillion-dollar opportunity in helping businesses modernize core IT and deploy AI faster. On the cybersecurity front, IBM’s Red Hat subsidiary launched “Project Lightwell” on May 28, committing $5 billion over several years and deploying more than 20,000 engineers to scan open-source software for vulnerabilities and provide commercial patches.

The stock’s technical picture reflects the tug-of-war. After a 30-day gain of 34%, the shares now sit 12.07% below their 52-week high of €292.85. The relative strength index stands at 65.6 in the primary analysis and 67.7 in the secondary, signaling the rally is no longer cheap but not yet overbought. The distance to the 50-day moving average is 22.09%, and to the 200-day average 9.75%. Monthly volatility has surged to 64.06%, underscoring the heightened event risk.

For investors, the next quarterly report will be pivotal. It will test whether corporate clients maintain their IT budgets in a higher-rate environment and whether IBM can back its AI and quantum narratives with tangible orders. The whistleblower case adds a legal wildcard that could revive scrutiny at a time when the company is selling security as a core differentiator. The outcome likely hinges on whether the new partnerships and product investments can sustain confidence even as the courtroom drama unfolds.